Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Measurement of Serum CA 19-9 May Be More Valuable Than CEA in Prediction of Recurrence in Patients With Gastric Cancer, American Journal of Clinical Oncology, April 2001, Wolters Kluwer Health,
DOI: 10.1097/00000421-200104000-00010.
You can read the full text:
Contributors
The following have contributed to this page
